1. Home
  2. ARWR vs EFSC Comparison

ARWR vs EFSC Comparison

Compare ARWR & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • EFSC
  • Stock Information
  • Founded
  • ARWR 2003
  • EFSC 1988
  • Country
  • ARWR United States
  • EFSC United States
  • Employees
  • ARWR N/A
  • EFSC N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • EFSC Major Banks
  • Sector
  • ARWR Health Care
  • EFSC Finance
  • Exchange
  • ARWR Nasdaq
  • EFSC Nasdaq
  • Market Cap
  • ARWR 1.8B
  • EFSC 2.0B
  • IPO Year
  • ARWR 1993
  • EFSC 1999
  • Fundamental
  • Price
  • ARWR $18.31
  • EFSC $57.36
  • Analyst Decision
  • ARWR Buy
  • EFSC Strong Buy
  • Analyst Count
  • ARWR 8
  • EFSC 3
  • Target Price
  • ARWR $43.71
  • EFSC $64.33
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • EFSC 207.4K
  • Earning Date
  • ARWR 08-07-2025
  • EFSC 07-28-2025
  • Dividend Yield
  • ARWR N/A
  • EFSC 2.10%
  • EPS Growth
  • ARWR N/A
  • EFSC 9.23
  • EPS
  • ARWR N/A
  • EFSC 5.09
  • Revenue
  • ARWR $545,209,000.00
  • EFSC $619,222,000.00
  • Revenue This Year
  • ARWR $21,924.50
  • EFSC $14.06
  • Revenue Next Year
  • ARWR N/A
  • EFSC $4.85
  • P/E Ratio
  • ARWR N/A
  • EFSC $11.25
  • Revenue Growth
  • ARWR 1436.97
  • EFSC 6.50
  • 52 Week Low
  • ARWR $9.57
  • EFSC $39.47
  • 52 Week High
  • ARWR $30.41
  • EFSC $63.13
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 66.51
  • EFSC 65.09
  • Support Level
  • ARWR $16.45
  • EFSC $56.49
  • Resistance Level
  • ARWR $19.24
  • EFSC $58.17
  • Average True Range (ATR)
  • ARWR 0.79
  • EFSC 1.14
  • MACD
  • ARWR 0.25
  • EFSC 0.23
  • Stochastic Oscillator
  • ARWR 77.43
  • EFSC 85.38

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.

Share on Social Networks: